Search company, investor...
Search

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

amo-pharma.com

Founded Year

2015

Stage

Series B | Alive

Total Raised

$60M

Last Raised

$35M | 3 yrs ago

About AMO Pharma

AMO Pharma is working to identify and advance promising therapies for the treatment of serious and debilitating diseases in patient populations with significant areas of unmet need, including rare genetic diseases. AMO Pharma is currently advancing two investigational therapies for treatment of fragile X syndrome and myotonic dystrophy, and is in the process of licensing additional development-stage products in diverse areas including autism and other CNS disorders.

AMO Pharma Headquarters Location

152-160 City Road

London, England, EC1V 2NX,

United Kingdom

+44 (0) 1483 319070

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing AMO Pharma

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

AMO Pharma is included in 1 Expert Collection, including Biopharma Tech.

B

Biopharma Tech

15,535 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

AMO Pharma Patents

AMO Pharma has filed 1 patent.

The 3 most popular patent topics include:

  • Autosomal recessive disorders
  • Neurological disorders
  • Psychiatric diagnosis
patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/25/2018

Syndromes, Rare diseases, Autosomal recessive disorders, Psychiatric diagnosis, Neurological disorders

Application

Application Date

10/25/2018

Grant Date

Title

Related Topics

Syndromes, Rare diseases, Autosomal recessive disorders, Psychiatric diagnosis, Neurological disorders

Status

Application

Latest AMO Pharma News

AMO Pharma Announces Additional Private Equity Investment Following Progress in Phase 3 Study in Congenital Myotonic Dystrophy -...

May 10, 2022

Newswire UK 5h agoPrivate EquityprnewswireViews: 26 Not a member yet? Breaking News 24/7/365 ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY.CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN.PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS.THIS IS NOT A SOLICITATION FOR INVESTMENT.THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY.IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES.ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM.PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT. ALPHAMAVEN

AMO Pharma Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

AMO Pharma Rank

  • When was AMO Pharma founded?

    AMO Pharma was founded in 2015.

  • Where is AMO Pharma's headquarters?

    AMO Pharma's headquarters is located at 152-160 City Road, London.

  • What is AMO Pharma's latest funding round?

    AMO Pharma's latest funding round is Series B.

  • How much did AMO Pharma raise?

    AMO Pharma raised a total of $60M.

  • Who are the investors of AMO Pharma?

    Investors of AMO Pharma include Woodford Investment Management.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.